Back
54
Day Range
$86.15
$87.95
52-Week Range
$84.59
$114.44
Volume
1,737,987
50D / 200D Avg
$92.18
/
$95.23
Prev Close
$86.32
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 24.6 | 0.2 |
| P/B | 1.4 | 3.0 |
| ROE % | 5.6 | 3.6 |
| Net Margin % | 8.6 | 3.8 |
| Rev Growth 5Y % | 4.8 | 9.9 |
| D/E | 0.6 | 0.2 |
Analyst Price Target
Hold
$105.60
+20.5%
Low: $89.00
High: $122.00
Forward P/E
10.44
Forward EPS
$8.40
EPS Growth (est.)
+0.0%
Est. Revenue
8.55B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$10.91
$10.61 – $11.13
|
10.20B | 2 |
| FY2029 |
$10.34
$10.06 – $10.55
|
9.69B | 2 |
| FY2028 |
$9.54
$7.04 – $11.01
|
9.19B | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-10 | $2.40 | $2.42 | +0.8% |
| 2025-11-05 | $1.87 | $1.90 | +1.6% |
| 2025-08-07 | $1.98 | $2.07 | +4.5% |
| 2025-05-05 | $1.77 | $1.81 | +2.3% |
| 2025-02-06 | $2.30 | $2.31 | +0.4% |
| 2024-10-30 | $1.74 | $1.74 | 0.0% |
| 2024-08-07 | $1.99 | $2.01 | +1.0% |
| 2024-05-02 | $1.87 | $1.94 | +3.7% |
Dividend History
7 yr streakYield
0.01%
Payout Ratio
0.27%
Growth (3Y)
0.00%
Growth (5Y)
0.00%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Apr 30, 2026 | $0.24 | 1.10% |
| Dec 30, 2025 | Jan 30, 2026 | $0.24 | 1.06% |
| Sep 30, 2025 | Oct 31, 2025 | $0.24 | 0.97% |
| Jun 26, 2025 | Jul 31, 2025 | $0.24 | 1.05% |
| Mar 31, 2025 | Apr 30, 2025 | $0.24 | 0.85% |
| Dec 30, 2024 | Jan 31, 2025 | $0.24 | 0.91% |
| Sep 30, 2024 | Oct 31, 2024 | $0.24 | 0.89% |
| Jun 26, 2024 | Jul 31, 2024 | $0.24 | 0.89% |
| Mar 27, 2024 | Apr 30, 2024 | $0.24 | 0.72% |
| Dec 26, 2023 | Jan 31, 2024 | $0.24 | 0.79% |
| Sep 28, 2023 | Oct 31, 2023 | $0.24 | 0.85% |
| Jun 23, 2023 | Jul 31, 2023 | $0.24 | 0.67% |
| Mar 28, 2023 | Apr 28, 2023 | $0.24 | 0.76% |
| Dec 23, 2022 | Jan 31, 2023 | $0.24 | 0.76% |
| Sep 29, 2022 | Oct 31, 2022 | $0.24 | 0.89% |
| Jun 24, 2022 | Jul 29, 2022 | $0.24 | 0.87% |
| Mar 28, 2022 | Apr 29, 2022 | $0.24 | 0.75% |
| Dec 27, 2021 | Jan 31, 2022 | $0.24 | 0.75% |
| Sep 29, 2021 | Oct 29, 2021 | $0.24 | 0.64% |
| Jun 25, 2021 | Jul 30, 2021 | $0.24 | 0.58% |
Key Takeaways
Revenue grew 4.79% annually over 5 years — modest growth
Earnings declined -21.97% over the past year
Generating 1.47B in free cash flow
Cash machine — converts 208.81% of earnings into free cash flow
Capital efficient — spends only 2.73% of revenue on capex
Growth
Revenue Growth (5Y)
4.79%
Revenue (1Y)7.20%
Earnings (1Y)-21.97%
FCF Growth (3Y)11.37%
Quality
Return on Equity
5.60%
ROIC5.05%
Net Margin8.57%
Op. Margin16.55%
Safety
Debt / Equity
0.59
Current Ratio1.98
Interest Coverage4.65
Valuation
P/E Ratio
24.63
Forward P/E10.44
P/B Ratio1.37
EV/EBITDA17.84
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.20% | Revenue Growth (3Y) | 5.51% |
| Earnings Growth (1Y) | -21.97% | Earnings Growth (3Y) | -17.01% |
| Revenue Growth (5Y) | 4.79% | Earnings Growth (5Y) | 15.11% |
| Profitability | |||
| Revenue (TTM) | 8.23B | Net Income (TTM) | 705.20M |
| ROE | 5.60% | ROA | 3.05% |
| Gross Margin | 61.62% | Operating Margin | 16.55% |
| Net Margin | 8.57% | Free Cash Flow (TTM) | 1.47B |
| ROIC | 5.05% | FCF Growth (3Y) | 11.37% |
| Safety | |||
| Debt / Equity | 0.59 | Current Ratio | 1.98 |
| Interest Coverage | 4.65 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | 0.27% |
| Dividend Growth (3Y) | 0.00% | Dividend Growth (5Y) | 0.00% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 24.63 | Forward P/E | 10.44 |
| P/B Ratio | 1.37 | P/S Ratio | 2.11 |
| PEG Ratio | -1.26 | Forward PEG | N/A |
| EV/EBITDA | 17.84 | Fwd EV/EBITDA | 10.77 |
| Forward P/S | 2.03 | Fwd Earnings Yield | 9.58% |
| FCF Yield | 8.48% | ||
| Market Cap | 17.37B | Enterprise Value | 24.30B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8.23B | 7.68B | 7.39B | 6.94B | 6.83B |
| Net Income | 705.20M | 903.80M | 1.02B | 231.40M | 401.60M |
| EPS (Diluted) | 3.55 | 4.43 | 4.88 | 1.10 | 1.91 |
| Gross Profit | 5.07B | 5.49B | 5.31B | 4.92B | 4.87B |
| Operating Income | 1.36B | 1.29B | 1.28B | 696.30M | 860.30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 23.09B | 21.37B | 21.50B | 21.07B | 23.46B |
| Total Liabilities | 10.39B | 8.89B | 9.01B | 9.04B | 10.79B |
| Shareholders' Equity | 12.71B | 12.47B | 12.48B | 12.02B | 12.66B |
| Total Debt | 7.52B | 6.20B | 5.77B | 5.70B | 7.07B |
| Cash & Equivalents | 591.90M | 525.50M | 415.80M | 375.70M | 378.10M |
| Current Assets | 5.12B | 4.67B | 4.61B | 4.43B | 4.89B |
| Current Liabilities | 2.58B | 2.45B | 2.86B | 2.36B | 3.47B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#337 of 1049
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026